Patients are at the center of everything we do, defining and uniting our efforts for rare diseases, multiple sclerosis, oncology and immunology.
A Leader in Specialty Care
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, oncology and immunology. We bring hope to people with debilitating and complex genetic conditions that are often difficult to diagnose and treat.
Founded as Genzyme in Boston in 1981, Sanofi Genzyme is one of the world’s leading biotechnology companies, focused on developing highly specialized treatment.
In Pakistan, Sanofi Genzyme started its operations in 2013. We have improved the diagnosis of rare diseases in Pakistan through physician education, awareness programs, support of testing and screening initiatives and provision of cutting-edge free of cost therapies to some patients through global humanitarian programs.
It gives us immense pride to be the company that makes treatments available in Pakistan for Multiple Sclerosis (a disease of the central nervous system) and various genetic conditions, such as, Gaucher, Fabry, MPS I, Pompe diseases, as well as certain thyroid cancers.
Given the rare nature of genetic conditions, there are very few patient support groups/healthcare societies and that too with limited resources. Sanofi Genzyme has forged alliance with physician and patient communities to bring to light numerous issues and challenges encountered by patients, care-givers and families of rare diseases and MS
Signs and Symptoms of Rare Diseases
Rare diseases are often difficult to diagnose.
Sanofi Genzyme -- offering innovative solutions to patients of rare diseases
We have given hope to rare disease patients
Raisa was diagnosed with Gaucher disease in 2011. Hailing from Jaranwala, Raisa and her elder brother were both diagnosed with Gaucher at a young age. But unlike her brother whose diagnosis took several years and resulted in the removal of his spleen, Raisa was fortunate enough to get treatment soon after her diagnosis.
Raisa is her father’s darling who is grateful for scientific advancements which has led to the discovery of life-changing treatments that hold promise and hope for patients of rare diseases, especially in a developing country like Pakistan where access to treatment for rare conditions is a major concern.
Born in 2001, Aaiman was diagnosed with Gaucher disease at age 3. Her father who practiced medicine at the time felt extremely helpless because he himself could not figure out the cause of abnormal developments in Aaiman’s body. Initially, Aaiman was (mis)diagnosed with malaria because her large spleen appeared to indicate symptoms of malaria. Later, when Aaiman was diagnosed with Gaucher, her parents were devastated to find out the disease had no treatment available in Pakistan. Aaiman’s family made ardent efforts to approach relevant institutions and hospitals to seek treatment for Aaiman. In 2008, Aaiman received her first treatment. Her father believes it is the treatment that has made all the difference in their lives and given him back his daughter.
Cousin marriages may cause LSDs in children
Rare Diseases are mostly genetic